Q2 2025 Management View Kabir Kumar Nath, CEO, announced the appointment of Justin Gover, former CEO of GW Pharmaceuticals, ...

Robert Reffkin, Compass CEO, joins 'Squawk Box' to discuss the company's quarterly earnings results, state of the real estate ...

Compass Pathways fell on Phase 3 data but remains on track for an FDA filing despite dilution risks and volatility. Find out ...

The two parties are working to agree to the terms of the expedited discovery for Compass’s motion for preliminary injunction.

The battle between the industry giants over exclusive listings is the latest tussle in the space beset by infighting ...

CEO Robert Reffkin touted his brokerage hitting record numbers in metrics like revenue, market share and principal agent ...

This is Compass’s second acquisition this month and fifth within the past year, as the firm looks to establish 30% market ...

Researchers have discovered a protein which is critical for steering melanoma cancer cells as they spread throughout the body ...

Compass Inc (NYSE:COMP) is set to release its Q2 2025 earnings on Jul 30, 2025. The consensus estimate for Q2 2025 revenue is ...

The Basic Materials group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Compass Minerals (CMP) been one of those stocks this ...

Mumbrella Media has confirmed dates for this year’s Compass event series, which will take place across six Australian ...

TeraWulf Inc. (NASDAQ:WULF) is one of the best strong buy stocks to buy under $10. In a report released on July 24, Ed Engel ...